Product Images Ocella

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Ocella NDC 53002-1577 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 2 - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 02

Figure 2 - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 02

Structural Formulas - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 03

Structural Formulas - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 03

Drospirenone and Ethinyl estradiol are two active ingredients commonly found in combination birth control pills. Drospirenone is a synthetic form of progesterone, while Ethinyl estradiol is a synthetic form of estrogen. Together, they work to prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the lining of the uterus. These ingredients are effective and commonly prescribed by healthcare providers for contraception purposes.*

Pregnancy Diagram - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 04

Pregnancy Diagram - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 04

This text appears to be discussing different methods of birth control. It mentions various options such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, withdrawal, and not having sex during the most fertile days of the monthly cycle. The text also includes statistics on the number of pregnancies per 100 women, ranging from fewer than 1 to 85 or more.*

Ocella Foil - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 05

Ocella Foil - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 05

Blood Clot Diagram - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 06

Blood Clot Diagram - 7ae51f8c 8ea0 4502 8d7b d0c0b1a295ba 06

The text provides information about various ranges and factors related to pregnancy, postpartum, and the risk of blood clots. It mentions different categories such as non-pregnant, non-COC users, COC users, pregnancy, and postpartum. It also includes the number of women with a blood clot out of 10,000 Women Years. Additionally, it notes that the pregnancy data is based on the actual duration of pregnancy in reference studies and provides the rate of blood clot risk assuming a nine-month pregnancy duration.*

fig 1 - image 01

fig 1 - image 01

Figure 3: Relative Studies of Risk of Breast Cancer with Combined Oral Contraceptives - image 02

Figure 3: Relative Studies of Risk of Breast Cancer with Combined Oral Contraceptives - image 02

Label Image - lbl530021577

Label Image - lbl530021577

Not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.